Systems Immunology” section should center on analyses of novel immensely colossal data sets, engendered by the authors, which will accommodate as utilizable resources for future work in the field. The authors’ informatics analyses should sanction them to draw concrete conclusions, fortified by the data, about the biology of the system(s) under study. Alternatively, manuscripts may describe a novel method of data analysis, which could be applied to publicly available data sets. The latter type of manuscript must convincingly demonstrate the utility of the incipient analysis method to reveal novel biological insights about the system(s) under study. However, it is not obligatory for either type of manuscript to include definitive mechanistic analysis or experiments beyond those obligatory for the acquisition of reproducible and consequential data sets.
Transplantation
Tumor Immunology
Novel Immunological Methods (optically discern Editorial)
Manuscripts submitted to the Novel Immunological Methods section should provide an incipient approach to paramount immunological quandaries. The manuscript should validate the technique, reagent, or genetically manipulated line of mice (and provide data on that) and designate their utility for solving an immunologically fascinating quandary, but it is not compulsory for the manuscript to solve that quandary. The manuscript is evaluated on whether the technique, reagent, or line of mice is better than what is currently available and could consequently advance the field, as well as the usefulness of the technique, reagent, or line of mice to the field.